TrialJournal for immunotherapy of cancer2026

Simplified perioperative serplulimab and chemotherapy for resectable squamous NSCLC: a phase II trial with biomarker analysis.

Fangqiu Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.